Amyloid transthyretin cardiomyopathy (ATTR-CM) is a progressive and life-threatening heart disease that can lead to increased ventricular wall thickness, restrictive cardiomyopathy, and heart failure.

Treatment with risdiplam over 30 months led to overall clinically meaningful improvement in most adult patients with SMA type 2 or 3, a study found.

The EGPA treatment mepolizumab has shown safety and efficacy in decreasing the absolute number of eosinophils in peripheral blood and tissues.

SUDEP, sudden death in viral pneumonia, or a combination could be the cause of death in a patient with in Dravet syndrome (DS) and COVID-19.

A recent case report noted that a male patient was initially suspected of having IgG4-RD, only for his diagnosis to be revised to Castleman disease.

Are you a healthcare provider looking for information on Diffuse Large B-Cell Lymphoma Epidemiology? Read about it here.

The CSHA Clinical Frailty Scale is a feasible tool for predicting treatment-related toxicity and discontinuation in older adults with CLL.

Healthcare providers and caregivers caring for patients with hemophilia expressed a need for better provision of timely information.

Test your knowledge about the treatment of chronic lymphocytic leukemia (CLL) with this quiz and compare your results with other quiz takers.

The administration of ARGX-119 led to improved survival and muscle function in a passive transfer myasthenia gravis (MG) mice model, a study found.

Researchers have proposed a link between the availability of maternal-fetal medicine (MFM) physicians and decreased rates of maternal mortality.

New research shows the KIT p.D816V mutation is a significant predictor of adverse events during honeybee VIT and can predict VIT failure after wasp VIT.